Cite
Mshaik R, Simonet J, Georgievski A, et al. HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias. Blood Cancer J. 2021;11(3):61doi: 10.1038/s41408-021-00450-2.
Mshaik, R., Simonet, J., Georgievski, A., Jamal, L., Bechoua, S., Ballerini, P., Bellaye, P. S., Mlamla, Z., Pais de Barros, J. P., Geissler, A., Francin, P. J., Girodon, F., Garrido, C., & Quéré, R. (2021). HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias. Blood cancer journal, 11(3), 61. https://doi.org/10.1038/s41408-021-00450-2
Mshaik, Rony, et al. "HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias." Blood cancer journal vol. 11,3 (2021): 61. doi: https://doi.org/10.1038/s41408-021-00450-2
Mshaik R, Simonet J, Georgievski A, Jamal L, Bechoua S, Ballerini P, Bellaye PS, Mlamla Z, Pais de Barros JP, Geissler A, Francin PJ, Girodon F, Garrido C, Quéré R. HSP90 inhibitor NVP-BEP800 affects stability of SRC kinases and growth of T-cell and B-cell acute lymphoblastic leukemias. Blood Cancer J. 2021 Mar 18;11(3):61. doi: 10.1038/s41408-021-00450-2. PMID: 33737511; PMCID: PMC7973815.
Copy
Download .nbib